References
- Min HG. Clinical endocrinology. Seoul : Korea medicine. 1990 : 475-87.
- Wilson JD, Daniel MD, Foster W, Willliams MD. Textbook of endocrinology. 7th ed. Philadelphia : W. B. Saunders Company. 1985 : 1081-98.
- Bjorntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand Suppl. 1988 ; 723 : 121-34.
- Visscher TL. The public health impact of obesity. Annu Rev Pub Health. 2001 ; 22 : 355-75. https://doi.org/10.1146/annurev.publhealth.22.1.355
- Lee HK. Diseases associated with obesity. J Nut Health. 1990 ; 23(5) : 341-6.
- Yang KM. Relationship between the assessment of obesity and cardiovascular diseases. JKFN. 2002 ; 7(2) : 1-8.
- Yoon YS, Keum OS, Lee WS, Kim IH, Lee HI, Yong YS. Effects of Cheongshimyeonja-tang on body weight and serum lipid levels in high fat diet induced obese mice. Herb Formula Sci. 2014 ; 22(1) : 123-39. https://doi.org/10.14374/HFS.2014.22.1.123
- The Society of Korean Medicine Rehabilitation. Korean medicine rehabilitation. 4th ed. Seoul : Koonja Publishing Inc. 2015 : 298-317.
- Kim HG, Keum BT. The bibliographical study on causes, mechanisms and the chief virtues on obesity. J Daejeon Orient Med Coll. 1992 ; 1(2) : 61-71.
- Hwang MY, Kim WH. The study of oriental pothological physiology on obesity. J Daegu Orient Med Coll East West Med. 1984 ; 8(3) : 77-83.
- Heo SY, Kang HS. The study and treatment of East-West medicine on obesity. J Orient Rehab Med. 1997 ; 7(1) : 272-83.
- Song YS, Lee MJ, Jeong SH, Lee JS, Kim SS, Shin HD. Effects of Bangkihwangkitang, Bangkihwangkitang with Lycii fructus and Lycii fructus on the weight of obese rats. J Orient Rehab Med. 1991 ; 1(1) : 25-43.
- Lee ES, Kim SS, Jeong SH, Lee JS, Shin HD. Effects of Bangkihwangkitang on adipose tissue of liver and epididymis and serum lipid. J Orient Rehab Med. 1995 ; 5(1) : 1-10.
- Hwang MJ, Shin HS, Song MY. Review of literature on herbal medicines for the treatment of obesity in Korea: mainly papers since 2000. Orient Rehab Med. 2006 ; 16(3) : 65-81.
- Won JS. Dongeuisasangshinpyeon. Seoul : Jonghapeuiwonsa. 1974 : 66-7.
- Lee JM. Dongeuisusebowon. Seoul : Henglim Publishing Inc. 1986 : 7-13, 115, 137-8.
- Ahn HM, Han SY, Kim JH, Rho TW, Chong MS, Kim YK. Effects of Cheongpyesagan-tang and YKK012 on in vitro and in vivo colon cancercell growth with and without CPT-11. Kor J Herbol. 2015 ; 30(1) : 33-43. https://doi.org/10.6116/KJH.2015.30.1.33.
- Park YJ, Kim SJ, Yang GE, Lee MJ, Lee JS, Kang DH, et al. Anti-platelet aggregation effect of Cheongpyesagan-tang in vitro. Korean J Orient Int Med. 2010 ; 31(4) : 714-21.
- Choi DJ, Jung WS, Moon SK, Cho KH, Kim YS, Bae HS. The clinical efficacy of Chungpyesagan-tang on acute stroke. J Korean Orient Med. 2002 ; 23(4) : 9-14.
- Hong SG, Joo KB, Jin KY, Mo KS, Wuk CD. Protective effects of Chungpesagan-tang against ischemia/reperfusion induced cell injury. Korea Inst Orient Med. 2000 ; 54(1) : 111-7.
- Jeong CG, Kim EY, Shin JW, Sohn YJ, Lee HS, Jung HS, et al. Effect of Chungpaesagan-tang on ischemic damage induced by middle cerebralartery occlusion in diabetic rats. J Korean Orient Med. 2005 ; 26(2) : 217-30.
-
Kim JY, Shin MR, Heo WY, Kim DR, Weon JJ. The effects of Chungpyesagan-tang on the recovery of liver function in rat injured by
$CCl_4$ . J Sasang Const Med. 2005 ; 17(1) : 130-41. - Kim DL, Song YB. An experimental study of the effect by Chongshimyonjatang and Chongpyesagantang on immune response and anti-allergic reaction to rats and mice. J KyungHee Orient Med Coll. 1991 ; 14 : 131-60.
- Koo JS. Effects of Chungpyesagantang on the diabetic rats induced by streptozotocin. J Korean Orient Pediatr. 1997 ; 11(1) : 227-48.
- Song MY, Kim SS, Shin HD. The clinical study about the effect of Chugpaesagan-tang and Taeumjoui-tang on Taeumin obesity after fasting therapy. J Orient Rehab Med. 1998 ; 8(1) : 34-56.
- Kim EY, Sul YK, Choi JJ, Jeon SH, Kim H, Kim JW. Effect of Cheongpesagan-tang on the change of inhibitory effect against lipase activity and weight loss, plasma and UCP1, 2mRNA expression in db/db mouse. J Sasang Const Med. 2007 ; 19(1) : 171-85.
- Bae JH, Lee JS, Chung SH, Kim SS, Shin HD. Effect of Cheongpesagan-tang on the changes of the weight, plasma and UCP mRNA expression in obese SD rats induced high fat feed. J Orient Rehabil Med. 2002 ; 12(1) : 133-56.
- Huh SY, Kang HS. Experimental study on the effect of Chungpesagantang in obese rats. Orient Rehab Med. 1998 ; 8(2) : 106-18.
- Hwang JH, Jang ES, Yoo JH, Lee SW. Clinical study on the utilization of Yeoldahanso-tang and Cheongpyesagan-tang. Korean Inst Orient Med. 2008 ; 14(2) : 101-6.
- Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipid from animal tissues. J Biol Chem. 1975 ; 226 : 497-509.
- Frings CS, Dunn RT. A colorimetric method for determination of total serum lipids based on the sulfo- phospho-vanillin reaction. Am J Clin Pathol. 1970 ; 53 : 89-91. https://doi.org/10.1093/ajcp/53.1.89
- Kim KS, Park SW. Drug therapy for obesity. Korean J Obes. 2012 ; 21(4) : 197-202. https://doi.org/10.7570/kjo.2012.21.4.197
- Kim SG, An GH, Yoon SW, Lee YC, Ha SD. A study on dietary supplement to reduce obesity by the mechanism of decreasing lipid and carbohydrate absorption. Korean J Food Sci Technol. 2003 ; 35(3) : 519-26.
- Jin KS. Analysis of the tendency to research for obesity. MS Thesis. Daejeon: Graduate School of Daejeon University. 2004.
- Gang SA, Jang GH, Park SG, Lim JP, Jeon H, Choi H, et al. Effects of herbal compositionon obese a high fat diet. Kor J Herbol. 2003 ; 18(4) : 59-64.
- Park WH, Yun YC, Yun KS, Park TY, Kim HJ, Won SC, et al. Review on the study of oriental obesity pattern identification: focused on Korean research papers. J Orient Rehabil Med. 2014 ; 24(2) : 84-93.
- Kang SA, Jang KH, Park SK, Lim JP, Jeon H, Cui X, et al. Effects of herbal composition on obese rats fed high diet. Kor J Herbol. 2003 ; 18 : 59-64.
- Shin MG. Herbal medicine. Seoul : Younglim Publishing. 2006 : 322, 341, 352, 400-1, 582-3, 720-1, 724, 749, 785.
- Moon SH, Sin SH, Kim HJ, Kim JY. A relationshipof the obesity and body composition analysisby Sasang constitution. J Orient Rehabil Med. 2002 ; 12(4) : 1-10.
- Jeong BS, Shin MG. Dohaehyangyak unabridged dictionary. Seoul : Younglim Publishing. 1990 : 116-9.
- Song YK, Lim HH. Clinical application of ma huang in the obesity treatment. J Soc Kor Med Obe Res. 2007 : 7(1) : 1-7.
- Kim KS, Lee DU, Kim YL, Hwang MJ, Kim GW, Koo BS. Anti-obesity and anti-hyperlipidemic effects of Taeyeumjoweetang and its modified prescription. 2007 ; 9(1) : 57-74.
- Lee GN, Kwon OH. The clinical pathology file. The 3rd ed. Seoul : Uihakmunhwasa. 2000 : 155-99.
- Tomkin GH. Atherosclerosis, diabetes and lipoproteins. Expert Rev Cardiovasc Ther. 2010 ; 8 : 1015-29. https://doi.org/10.1586/erc.10.45
- Avram AS, Avram MM, James WD. Subcutanous fat in normal and diseased status: 2. Anatomy and physiology of white and brown adipose tissue. J Am Acad Dermatol. 2005 ; 53 : 671-83. https://doi.org/10.1016/j.jaad.2005.05.015
- Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003 ; 112(12) : 1821-30. https://doi.org/10.1172/JCI200319451
- Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000 ; 11 : 327-32. https://doi.org/10.1016/S1043-2760(00)00301-5
- Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001 ; 86 : 1930-5. https://doi.org/10.1210/jcem.86.5.7463
- Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 2002 ; 360 : 57-8. https://doi.org/10.1016/S0140-6736(02)09335-2
- Fasshauer M, Paschke R. Regulation of adipokines and insulin resistance. Diabetologia. 2003 ; 46 : 1594-603. https://doi.org/10.1007/s00125-003-1228-z
- Diamond FB Jr, Cuthbertson D, Hanna S, Eichler D. Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab. 2004 ; 17 : 1069-75.
- Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, et al. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care. 2004 ; 27 : 2488-90. https://doi.org/10.2337/diacare.27.10.2488
- Darlington GJ, Ross SE, MacDougald OA. The role of C/EBP genes in adipocyte differentiation. J Biol Chem. 1998 ; 273 : 30057-60. https://doi.org/10.1074/jbc.273.46.30057
- Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, et al. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 1996 ; 15 : 5336-48 .
- Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002 ; 109 : 1125-31. https://doi.org/10.1172/JCI0215593
- Nepokroeff CM, Lakshmanan MR, Porter JW. Fatty acid synthase from rat liver. Methods Enzymol. 1975 ; 35 : 37-44. https://doi.org/10.1016/0076-6879(75)35136-7
- Cameron PJ, Rogers M, Oman J, May SG, Lunt DK, Smith SB. Stearoyl coenzyme A desaturase enzyme activity and mRNA levels are not different in subcutaneous adipose tissue from angus and American wagyu steers. J Anim Sci. 1994 ; 72 : 2624-8. https://doi.org/10.2527/1994.72102624x
- Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001 ; 50 : 2094-99. https://doi.org/10.2337/diabetes.50.9.2094
- Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, et al. Induction of adipocyte complement-related protein of 30kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrionology. 2002 ; 143 : 998-1007. https://doi.org/10.1210/endo.143.3.8662
- Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med. 2001 ; 7 : 947-53. https://doi.org/10.1038/90992
- Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A. 2001 ; 98 : 2005-10. https://doi.org/10.1073/pnas.98.4.2005
-
Huang J, Jia Y, Fu T, Viswakarma N, Bai L, Rao MS, et al. Sustained activation of
$PPAR{\alpha}$ by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J. 2012 ; 26(2) : 628-38. https://doi.org/10.1096/fj.11-194019
Cited by
- 동물실험에서 한약제재 경구투여가 비만에 미치는 영향에 대한 국내 연구보고 고찰 - 2010년 이후 발표된 논문을 중심으로 vol.27, pp.3, 2015, https://doi.org/10.18325/jkmr.2017.27.3.13
- 고지방식이 유도 비만생쥐에 대한 영계출감탕(苓桂朮甘湯) 가(加) 황기(黃芪)의 항비만 효과 vol.28, pp.2, 2015, https://doi.org/10.18325/jkmr.2018.28.2.1
- 최근 10년간 한방비만학회지의 연구동향 분석: 2010-2019년 한방비만학회지 게재논문을 중심으로 vol.20, pp.2, 2015, https://doi.org/10.15429/jkomor.2020.20.2.149